Powerhouse Podcast #29: Pierrepoint and the Mito Fund

In this latest episode, join UMDF's Brian Harman and Dr. Philip Yeske in a talk with guests, Todd Lacey from the UMDF Board of Trustees and Dan DiPietro, Co-Founder of Pierrepont Therapeutics. On the advent of The Mito Fund's inaugural investment in Pierrepont's enzyme replacement therapy for patients with MNGIE, they share insight on the potentially game-changing research investment and new strategic partnership.

[@MitocondrialPolG]

I'm MTDPS4B or MNGIE related PolG gene

[@beckyyu3726]

i have Polg 1. dx causing CPEO Do u have trouble walking? thx Becky

[@lizw2202]

Drug approval? Where do I begin?

[@beckyyu3726]

you do a clinical trial. Its hard to get dx but there are opportunities to get genetic testing.